IPP Bureau
TPAG organizes Thalassemia & SCD prevention discussion
By IPP Bureau - April 29, 2023
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
PI Industries announces twin acquisitions into Pharma API & CDMO space
By IPP Bureau - April 28, 2023
Laurus Labs Q4 FY23 consolidated PAT drops to to Rs. 102.98 Cr
By IPP Bureau - April 28, 2023
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
Yuyu Pharma unveils the results of its studies for its dry eye treatment peptide
By IPP Bureau - April 28, 2023
The YP-P10 pre-clinical head-to-head study, jointly conducted by five people including Dr. Kyungho Park of Naason Science
Yasmin and Mirena to take back seat from Bayer’s future drug strategy, says GlobalData
By IPP Bureau - April 28, 2023
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
Cipla partners with MNCs to strengthen anti-diabetes innovative portfolio: GlobalData
By IPP Bureau - April 28, 2023
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Ipca Laboratories gets 3 observations for Piparia, Silvassa unit
By IPP Bureau - April 27, 2023
The company will submit its comprehensive response on these observations to the US FDA within the stipulated time
Biocon approves NCD issue
By IPP Bureau - April 27, 2023
The return profile of NCDs is linked to BBL share price subject to minimum IRR of 12%.
Syngene International posts Q4 FY2023 consolidated profit at Rs. 178.7 Cr
By IPP Bureau - April 27, 2023
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
Venus Remedies secures marketing authorization from UK MHRA for Cisplatin
By IPP Bureau - April 27, 2023
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
Siegfried breaks ground on new R&D center for drug substances in Switzerland
By IPP Bureau - April 26, 2023
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
Tricog raises US$ 8.5 million in series B2 funding
By IPP Bureau - April 25, 2023
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Xyall and Indica Labs forge collaboration to transform precision oncology workflows
By IPP Bureau - April 25, 2023
Bridging the gap between histopathology and molecular pathology
Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 Cr
By IPP Bureau - April 25, 2023
The business and product range of Ipca and that of Unichem complements each others business and product range
Aster RV Hospital launch needleless injections in South India
By IPP Bureau - April 25, 2023
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
